Free Trial

Tilray (TLRY) Competitors

Tilray logo
$0.40 -0.01 (-2.71%)
As of 01:29 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TLRY vs. CRON, CDXC, MNMD, USNA, UPXI, SNDL, ACB, CGC, MDWD, and BTMD

Should you be buying Tilray stock or one of its competitors? The main competitors of Tilray include Cronos Group (CRON), ChromaDex (CDXC), Mind Medicine (MindMed) (MNMD), USANA Health Sciences (USNA), Upexi (UPXI), SNDL (SNDL), Aurora Cannabis (ACB), Canopy Growth (CGC), MediWound (MDWD), and biote (BTMD). These companies are all part of the "medicinals & botanicals" industry.

Tilray vs. Its Competitors

Tilray (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

Cronos Group has lower revenue, but higher earnings than Tilray. Tilray is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray$210.48M1.95-$244.98M-$1.05-0.39
Cronos Group$124.59M6.02-$73.96M$0.1314.96

Tilray currently has a consensus target price of $1.92, suggesting a potential upside of 369.77%. Given Tilray's stronger consensus rating and higher possible upside, equities research analysts plainly believe Tilray is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Tilray had 3 more articles in the media than Cronos Group. MarketBeat recorded 5 mentions for Tilray and 2 mentions for Cronos Group. Cronos Group's average media sentiment score of 1.05 beat Tilray's score of 0.63 indicating that Cronos Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cronos Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tilray has a net margin of -30.95% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -2.56% beat Tilray's return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray-30.95% -4.40% -3.57%
Cronos Group -42.65%-2.56%-2.47%

9.4% of Tilray shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.6% of Tilray shares are held by insiders. Comparatively, 7.3% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Cronos Group received 16 more outperform votes than Tilray when rated by MarketBeat users. Likewise, 61.13% of users gave Cronos Group an outperform vote while only 59.10% of users gave Tilray an outperform vote.

CompanyUnderperformOutperform
TilrayOutperform Votes
448
59.10%
Underperform Votes
310
40.90%
Cronos GroupOutperform Votes
464
61.13%
Underperform Votes
295
38.87%

Tilray has a beta of 1.83, suggesting that its share price is 83% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500.

Summary

Tilray and Cronos Group tied by winning 9 of the 18 factors compared between the two stocks.

Get Tilray News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilrayMedicinals & botanicals IndustryStaples SectorNASDAQ Exchange
Market Cap$409.64M$1.23B$17.50B$8.57B
Dividend YieldN/AN/A3.07%4.17%
P/E Ratio-1.3612.9516.3519.81
Price / Sales1.9511.0943.31154.51
Price / CashN/A10.4016.3934.64
Price / Book0.101.466.134.65
Net Income-$244.98M-$56.07M$734.57M$248.05M
7 Day Performance0.59%-2.24%0.07%-0.15%
1 Month Performance-9.41%-0.54%-0.64%4.50%
1 Year Performance-76.69%-33.28%2.28%13.76%

Tilray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray
1.9446 of 5 stars
$0.41
-2.0%
$1.92
+369.8%
-76.5%$409.64M$210.48M-1.362,650
CRON
Cronos Group
1.6895 of 5 stars
$1.96
-0.3%
N/A-20.4%$754.01M$124.59M-15.04450Positive News
CDXC
ChromaDex
2.6162 of 5 stars
N/A$9.03
+∞
N/A$611.50M$99.60M787.29120
MNMD
Mind Medicine (MindMed)
1.9298 of 5 stars
$8.06
+3.9%
$25.50
+216.4%
-7.0%$608.58MN/A-3.5640Positive News
Analyst Revision
Gap Down
USNA
USANA Health Sciences
4.0427 of 5 stars
$30.74
+3.1%
$36.00
+17.1%
-35.5%$572.19M$876.24M10.861,900
UPXI
Upexi
1.0235 of 5 stars
$12.12
+1.0%
N/A+26.9%$461.05M$16.56M0.00130Short Interest ↑
SNDL
SNDL
3.6129 of 5 stars
$1.33
-0.4%
$3.63
+173.6%
-34.1%$348.18M$927.61M-4.27580
ACB
Aurora Cannabis
0.3 of 5 stars
$5.93
+1.9%
N/A+0.7%$332.51M$320.81M118.321,340Upcoming Earnings
CGC
Canopy Growth
2.5611 of 5 stars
$1.55
-4.6%
$2.00
+29.4%
-79.8%$284.07M$269.00M-0.413,150Positive News
MDWD
MediWound
2.0686 of 5 stars
$21.48
+0.1%
$31.80
+48.0%
+26.6%$232.16M$19.21M-7.4180
BTMD
biote
3.8941 of 5 stars
$4.06
+3.3%
$8.00
+97.0%
-40.4%$221.90M$199.38M15.60194

Related Companies and Tools


This page (NASDAQ:TLRY) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners